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ABSTRACT: These studies aimed at assessing platelet profile in the three trimesters of pregnancy.Subjects were 
apparently healthy volunteers who were staff, students and antenatal patients of a Hospital in Benin. Platelet profile was 
assessed using Swelab Alfa Basic model Haematological Analyser (Boule Medical AB, Stockholm, Sweden). The 
results were presented as mean ± SEM in tables and graphs and analysed using One Way Analysis of Variance and 
Duncan post Hoc test and p < 0.05 was considered significant. The study showed that platelet count x 103/µl (277.83 ± 
36.33; first trimester > 193.60 ± 13.15; second trimester > 185.50 ± 11.58; third trimester) and plateletcrit in percentage 
(0.22 ± 0.03; first trimester > 0.17 ± 0.01; second trimester > 0.16 ± 0.01; third trimester) reduced progressively as 
pregnancy advanced and this was statistically significant (p < 0.05) when compared to control of 276.17 ± 34.32 x103/µl 
and 0.20 ± 0.20 respectively. A similar pattern was observed for Mean Platelet Volume (MPV). However, Platelet 
Width Density (PDW) in percentage increased (10.52 ± 0.22; first trimester < 13.44 ± 0.30; second trimester < 13.65 ± 
0.41; third trimester) as pregnancy advanced. Thus PDW compensates for these reductions and a lack of this 
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Platelet studies have evolved from its customary 
function in hemostasis to other functions such as 
inflammation, innate immunity, wound healing and 
angiogenesis (Kakali, 2013). In pregnancy several 
hematological, biochemical and hemodynamic 
modifications occur as part of the physiological 
adaptation of the body to this condition (Rodríguez-
Dennen, 2011). These adaptations are meant to 
maintain the maternal, fetal and uteroplacental 
homestasis. Thrombocytes or platelets, red cells and 
white cells are essential for hemostasis, transport of 
oxygen and immunity respectively and their 
physiologic modification are particularly important 
during pregnancy. However, there have been 
controversies about the pattern of platelet profile in 
normal pregnancy, for instance Mohapatra et al 
(2007) reported  that platelet count increased as 
pregnancy advanced. This is in contrast to other 
studies that reported a fall in platelet count as 
pregnancy advanced (Bonar et al., 1969; Sejeny et 
al., 1975; Karim et al., 1992). Also, some researchers 
reported that there was no change in the platelets 
count as pregnancy advanced (Todd et al., 1965; 
Ratnoff., 1954; Tygart et al., 1986)  while others 
reported a fall of platelet count from the first 
trimester and a rise in the third trimester (Amah-
Tariah et al., 2011).  Amongst Chinese women, a 
gradual decrease in platelet count with no change in 
mean platelet volume has been reported (Liu et al., 
2011)
. 
Most of the studies done on platelet in 
pregnancy did not involve other platelet parameters 
such as Mean Platelet Volume (MPV), Plateletcrit 
(PCT) and Platelet Density Width (PDW).
 
This study 
is therefore aimed at assessing plate count and these 
additional parameters in the three trimesters of 
pregnancy.  
 
MATERIALS AND METHODS 
Study population: This cross sectional study was 
conducted on students, staff and antenatal patients of 
a hospital in Benin. A total of 400 apparently healthy 
subjects aged between 23-27years and parity between 
0-4 volunteered for the study. 100 subjects were in 
the non-pregnant control group while each of the 
three trimesters of pregnancy had 100 subjects each. 
Ethical clearance for the study was obtained from the 
Ethics and Collaboration Committee of the hospital. 
Informed consent was also obtained from each 
subject who volunteered for the study. Volunteers 
with history of cardiovascular disease in pregnancy, 
bleeding disorders, diabetes and drugs capable of 
affecting platelet count were excluded from the 
study.  
 
Measurement of Blood Pressure: Blood pressure was 
measured and recorded in mmHg as follows: after a 
rest period of about 30 minutes, the systolic and 
diastolic pressures were measured in each subject in 
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the sitting position on the brachial artery using 
auscultatory method. Diastolic pressure was 
determined as the disappearance of the Korotkoff’s 
sound.  
 
Blood Sample collection: 5ml of blood was drawn 
with minimum stasis from ante-cubital vein of 
subjects between 9am and 11 am each day in 
comfortable position and stored in an EDTA 
anticoagulated tube for platelet analysis. The blood 
samples were properly labeled and stored at room 
temperature until ready for analysis. All blood 
samples were collected between 9am and 11 am each 
day and analyzed within thirty minutes of collection.  
 
Sample analysis: Analysis of blood was done within 
thirty minutes of collection and the sample was 
thoroughly and gently mixed before analysis. Platelet 
count (PLT), Platelet Width Density (PDW), 
Plateletcrit (PCT), Mean Platelet Volume (MPV) 
were determined by flow cytometry using the Swelab 
Alfa Basic model hematological autoanalyzer (Boule 
Medical AB, Stockholm, Sweden) at room 
temperature (27.5±0.5°C).  
 
Statistical Analysis: Data were presented as mean 
value± standard error of mean. The means were 
tested for homogeneity using one way analysis of 
variance of Micro soft excel 2010 and the 
significance between means was tested using the 
Duncan post hoc test of SPSS version 20. A 
difference between two means was considered to be 
statistically significant with a p value < 0.05. 
 
RESULTS AND DISCUSSION 
Of the four hundred subjects that volunteered for the 
study, twenty six were disqualified because of the 
exclusion criteria enumerated in the methodology. 
Eleven of the disqualified subjects were from the first 
trimester of pregnancy, while fifteen were from the 
third trimester of pregnancy. No subject was 
disqualified from the second trimester of pregnancy 
and the non-pregnant control. Thus a total of 374 
subjects i.e. 93.50% of the volunteers were involved 
in the study. Table 1 shows the subjects 
demographics.
 







3rd  Trimester  
(n=85) 
Age(yrs) 24.11± 0.11 23.30± 0.33 25.00± 2.50 25.59± 1.50 

















Table 2: Platelet indices in the non-pregnant control and in three trimesters of pregnancy 
Parameters Control (n=100) 1st Trimester  
(n=89) 




PLT (x103/µl) 276.17±34.32 277.83 ± 36.33# 193.60 ± 13.15* 185.50 ± 11.58* 
MPV(fL) 9.14± 0.41 8.22 ± 0.31# 8.40 ± 0.23* 8.00 ± 0.29* 
PDW (%) 10.21± 0.18 10.52 ± 0.22# 13.44 ± 0.30* 13.65 ± 0.41* 
PCT (%) 0.20± 0.02 0.22 ± 0.03 0.17 ± 0.01* 0.16 ± 0.01* 
*P< 0.05 indicates a significant difference when compared to control while 
#
 P >0.05 indicates no significant 
difference when compared to control. 
 
This study revealed a fall in platelet count in the 
second and third trimesters of pregnancy (Table 2). 
This pattern of platelet count fall in the three 
trimesters of pregnancy was also observed in other 
studies (Sejeny et al., 1975; Karim et al., 1992).  The 
progressive fall in platelet count from mid-term to 
labor indicates a direct relationship between the 
plasma volume changes and the corresponding 
platelets counts (Shaper et al., 1968). Nevertheless, 
the progressive fall in platelet count as pregnancy 
advanced did not cause thrombocytopenia in these 
trimesters of pregnancy as the values were still within 
normal range of 150,000 and 450,000 per microliter 
of blood (150–450 × 10
9
/L). The decrease in the 
number of circulating platelets as pregnancy 
advances are due to normal physiologic changes 
characterized by increased blood volume, increase in 
platelet activation, increase platelet aggregation and 
increased platelet clearance (Matthews, 1990; Fay et 
al., 1983).Furthermore, placenta size enlarges with 
progression of gestation and consequently more 
capturing and destruction of platelet ensue (Shehata 
et al., 1999).  Thrombocytopenia is fairly common in 
pregnancy and it is caused by accelerated platelet 
consumption and decreased production (Shamoon et 
al., 2009). The etiology is unknown but is considered 
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to be due to the relative hemodilution in pregnancy 
(Copplestone, 1992; Dutta, 1998), amplified by the 
capture and destruction of platelets in the placenta 
(Shehata et al., 1999). A decreased platelet count as a 
function of placenta size is emphasized by a study 
which reported that 70% of the thrombocytopenic 
pregnant women were in the third trimester of 
pregnancy and none in the first trimester (Shamoon et 
al., 2009; Boehlen et al., 2000). Multiparty with 
larger placenta size (Monga, 2006) have been shown 
to have a reducing effect on platelet count possibly 
due to increased coagulation system in the placenta. 
Although, Mean platelet volume (MPV) and platelet 
distribution width (PDW) are known to increase 
during platelet activation (Vagdatli et al., 2010)
, 
only 
the latter increased in this study (Table 2). The 
observed increase in PDW is probably a physiologic 
compensation for the decreasing platelet count and 
volume as pregnancy advanced. Platelets having 
denser granules are bigger in size and metabolically 
more active (Dogan et al., 2012; Valkila et al., 1994). 
PDW is more specific than MPV for identification of 
platelet activity and it is a simple, practical and 
specific marker for enhanced coagulation (Vagdatli et 
al., 2010).  The plateletcrit in this study also 
decreased as pregnancy advanced possibly because of 
the hemodilution (Copplestone, 1992) of mid 
pregnancy till labour.  
 
The findings from this indicates that platelet count, 
Mean Platelet Volume (MPV) and plateletcrit 
reduced as pregnancy traverses its trimesters and this 
reduction is compensated for, by a physiologic 
increase in Platelet Width Density (PWD). However, 
pregnant women who have a setting for 
thrombocytopenia may be at a higher risk of the 
effect of this disorder in the third trimester of 
pregnancy.  Thus, PDW should be part of the routine 
investigations for ante natal women especially in the 
third trimester as a defect in this compensatory 
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